Resultado de búsqueda
24 de abr. de 2024 · The total national antidiabetic medication use has increased by 7.6% and reached 94.8 DDD/TID in 2021. Regarding antidiabetic subgroups, the use of metformin and novel antidiabetics (DPP4Is, GLP1As and SGLT2Is) and their combinations increased in all counties, while sulfonylurea consumption decreased, and insulin use was stable.
Hace 4 días · Diabetes is treated with several parenteral formulations of insulin and oral or parenteral noninsulin antidiabetic agents. Glucagon, a hormone that affects the liver, cardiovascular system, and gastrointestinal tract, can be used to treat severe hypoglycemia.
17 de abr. de 2024 · Sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reduced risk for atrial fibrillation (AF) regardless of diabetes duration, body mass index (BMI), and cardiovascular comorbidities among patients, but especially women, with type 2 diabetes, according to study results published in Cardiovascular Pharmacotherapy.
4 de may. de 2024 · To treat diabetes, there are eight main categories of drugs used.These categories include: metformin (usually the most common diabetes medications), sulfonylureas, meglitinides, thiazolidinediones, DPP-4 inhibitors, alpha-glucosidase inhibitors, SGLT2 inhibitors, or bile acid sequestrates.
27 de abr. de 2024 · The thematic series focusses on two groups of antidiabetic medications that have demonstrated cardiovascular benefits with consistently reduced major adverse cardiac events, improvement in heart failure and diminished cardiovascular and all-cause mortality.
27 de abr. de 2024 · ANTIDIABETIC MEDICATIONS AND THEIR EFFECTS ON PANCREATIC β-CELL FUNCTION AND MASS. Finding a medication to stop the reduction in β-cell mass and function in patients with type 2 diabetes mellitus is an important issue. The question whether pancreatic β-cell mass and function are directly impacted by antidiabetic drugs is still up ...
Hace 1 día · The major types of diabetes are type 1 and type 2, though other forms also exist. The most common treatment for type 1 is insulin replacement therapy (insulin injections), while anti-diabetic medications (such as metformin and semaglutide) and lifestyle modifications can be used to manage type 2.
